© 2005 Oxford University Press
ARTICLE |
Clonal History of Papillomavirus-Induced Dysplasia in the Female Lower Genital Tract
Affiliations of authors: Department of Molecular Pathology/Applied Tumor Biology, Institute of Pathology (SV, NW, HS, MvKD), Institute of Human Genetics (RK), Department of Obstetrics and Gynecology (PM), University of Heidelberg, Heidelberg, Germany; Department of Obstetrics and Gynecology (JE, MH), Institute of Pathology (L-CH), University of Leipzig, Leipzig, Germany; Gynaecological Molecular Biology, Department of Obstetrics and Gynaecology, University of Jena, Jena, Germany (CZ)
Correspondence to: Magnus von Knebel Doeberitz, MD, Department of Molecular Pathology/Applied Tumor Biology, Institute of Pathology, University of Heidelberg, Im Neuenheimer Feld 220, 69120 Heidelberg, Germany (e-mail: knebel{at}med.uni-heidelberg.de).
Background: Dysplastic lesions of the vagina or the vulva often occur in women who have a previous history of cervical dysplasia. Most lesions in the female lower genital tract are induced by infections with high-risk oncogenic human papillomaviruses (HR-HPVs), including HPV16 and HPV18. HR-HPV genomes frequently integrate into host cell chromosomes at random sites. We analyzed viral integration sites in multiple metachronous lesions of the lower genital tract from women previously treated for HR-HPV–positive cervical dysplasia or cancer to determine whether the metachronous lesions emerged from a single common preexisting dysplastic cell clone or as consequence of independent HR-HPV infection events in the female lower genital tract. Methods: From among 1500 patients with anogenital lesions, seven patients with high-grade vaginal or vulvar lesions and with a previous history of cervical disease (five with prior high-grade cervical dysplasia and two with a history of cervical cancer) were included in this study. Integration sites of HPV16 or HPV18 in vaginal or vulvar lesions were mapped by an adaptor ligation polymerase chain reaction (PCR) method. The sequence information was used to design an integrate-specific PCR assay that was applied to DNA extracted from archival paraffin-embedded material derived from biopsy samples of cervical lesions. Results: Identical HPV DNA integration loci were found in vaginal or vulvar and cervical samples of all lesions available for four of the five patients with a prior history of high-grade cervical dysplasia and for both patients with a history of cervical cancer. Conclusions: These data indicate that high-grade dysplastic lesions in the female lower genital tract may emerge primarily as monoclonal lesions from a transformed cell population derived from the uterine cervix.
CiteULike 
Connotea 
Del.icio.us What's this?
Editorial about this Article
- New and Surprising Insights Into Pathogenesis of Multicentric Squamous Cancers in the Female Lower Genital Tract
- Qinghua Feng and Nancy B. Kiviat
J Natl Cancer Inst 2005 97: 1798-1799.[Extract] [Full Text] [PDF]
This article has been cited by other articles:
|
|
 |
|
  K. M. Colegrove, F. M. D. Gulland, D. K. Naydan, and L. J. Lowenstine Tumor Morphology and Immunohistochemical Expression of Estrogen Receptor, Progesterone Receptor, p53, and Ki67 in Urogenital Carcinomas of California Sea Lions (Zalophus californianus) Vet. Pathol., July 1, 2009; 46(4): 642 - 655. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Feng and N. B. Kiviat New and Surprising Insights Into Pathogenesis of Multicentric Squamous Cancers in the Female Lower Genital Tract J Natl Cancer Inst, December 21, 2005; 97(24): 1798 - 1799. [Full Text] [PDF]
|
|